Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Ian Gilham, Julie Khani

Premium

Multiplicom said this week that it has appointed Ian Gilham as chairman of the board. Gilham was first COO, then CEO of in vitro diagnostics company Axis-Shield until it was acquired by Alere in November 2011. Prior to this, he was vice president of pharmacogenetics at GlaxoSmithKline. He has also held general management, marketing, business development, and R&D positions at Abbott Laboratories, Celltech, and Amersham.


The American Clinical Laboratory Association has named Julie Khani to be its senior vice president, a new position at the organization. Khani will oversee advocacy and policy operations, and will run a team of three vice presidents.

She recently was vice president of public policy at the National Association of Chain Drug Stores, and before that she was the association's director of federal and legislative affairs. Prior to her 11 years at NACDS, Khani was a legislative manager at Ford Motor Company.

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.